From: Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study
Age (yr)
Male
Female
AE
ADR
Young, < 50
26 (7.2)
2 (0.6)
18 (14.5)
3 (2.4)
Middle-aged, 50–69
125 (12.8)
10 (1.0)
83 (16.3)
8 (1.6)
Older, ≥70
84 (15.7)
6 (1.1)
115 (18.1)
7 (1.1)